AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

IDEXX Laboratories, Inc.

$504.7 -$165.29 (-24.67%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$506.53
Day Range
$500.61$510.9
Year Range
$500.61$769.98
Market Cap
39.81B
AVG Volume
625.26K
Trailing/Forward PE
35.44/30.1
PEG ratio
2.62
Dividend Yield
-
Next Earnings Date
2026-11-02
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
02B4B6B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q24.55B
26 Q14.45B
25 Q44.3B
25 Q34.17B
25 Q24.04B
25 Q13.93B
24 Q43.9B
24 Q33.84B
24 Q23.78B
24 Q13.72B
Net Income (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q21.14B
26 Q11.1B
25 Q41.06B
25 Q31.03B
25 Q2985.66M
25 Q1894.97M
24 Q4887.87M
24 Q3866.24M
24 Q2845.63M
24 Q1866.57M
Operating Income (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q21.46B
26 Q11.41B
25 Q41.36B
25 Q31.31B
25 Q21.26B
25 Q11.15B
24 Q41.13B
24 Q31.11B
24 Q21.08B
24 Q11.12B
EBITDA (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q21.62B
26 Q11.56B
25 Q41.51B
25 Q31.45B
25 Q21.4B
25 Q11.29B
24 Q41.28B
24 Q31.26B
24 Q21.22B
24 Q11.24B
Cash Flows (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q21.25B
26 Q11.08B
25 Q41.05B
25 Q3953.57M
25 Q2774.34M
25 Q1837.7M
24 Q4798.08M
24 Q3792.6M
24 Q2838.95M
24 Q1796.79M
EPS (USD) · TTM
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q214.12
26 Q113.56
25 Q413.07
25 Q312.61
25 Q212.01
25 Q110.82
24 Q410.67
24 Q310.37
24 Q210.1
24 Q110.33
Expenses (USD) · TTM
0500M1B1.5B2BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q21.5B
26 Q11.48B
25 Q41.42B
25 Q31.4B
25 Q21.36B
25 Q11.39B
24 Q41.38B
24 Q31.35B
24 Q21.33B
24 Q11.25B
Shares Outstanding (USD) · TTM
-500M0500M1B1.5BBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
IDXX Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q21.19B
26 Q11.17B
25 Q41.22B
25 Q31.21B
25 Q21.13B
25 Q11.02B
24 Q4776.74M
24 Q3566.63M
24 Q2381.64M
24 Q1166.47M
Employee Count
05K10K15K2016201720182019202020212022202320242025
IDXX Employee Count by quarter
PeriodEmployee Count
202511K
202411K
202311K
202210.78K
202110.35K
20209.3K
20199.2K
20188.38K
20177.6K
20167.37K
PE Ratio
30405060med 43.22Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IDXX PE Ratio by quarter
PeriodPE Ratio
Sep 2635.47
Sep 2637.63
Aug 2639.01
Aug 2639.14
Aug 2638.72
Aug 2641.23
Jul 2640.89
Jul 2639.81
Jul 2641.5
Jul 2641.21
Jul 2640.79
Jun 2640.33
Jun 2641.11
Jun 2641.02
Jun 2641.11
May 2641.21
May 2640.91
May 2638.67
May 2640.96
May 2642.9
Apr 2642.78
Apr 2644.55
Apr 2642.56
Apr 2643.06
Mar 2642.21
Mar 2643.64
Mar 2643.38
Mar 2646
Feb 2649.65
Feb 2648.06
Feb 2649.06
Feb 2650.25
Jan 2652.27
Jan 2654.09
Jan 2655.77
Jan 2655.61
Jan 2652.23
Dec 2553.67
Dec 2554.6
Dec 2554.9
Dec 2555.67
Nov 2558.69
Nov 2556.59
Nov 2553.79
Nov 2555.23
Oct 2551.36
Oct 2552.28
Oct 2551.84
Oct 2550.27
Oct 2551.49
Sep 2551.58
Sep 2553.53
Sep 2552.31
Sep 2552.46
Aug 2552.79
Aug 2552.67
Aug 2553.1
Aug 2553.69
Aug 2548.66
Jul 2551.35
Jul 2546.76
Jul 2548.46
Jul 2549.7
Jun 2548.28
Jun 2547.6
Jun 2547.49
Jun 2547.69
May 2546.65
May 2545.57
May 2547.08
May 2544.68
May 2542.88
Apr 2540.32
Apr 2537.93
Apr 2536.04
Apr 2536.3
Mar 2538.34
Mar 2538.81
Mar 2538.28
Mar 2539.65
Feb 2540.29
Feb 2541.74
Feb 2542.24
Feb 2543.69
Jan 2540.1
Jan 2541.36
Jan 2539.84
Jan 2539.72
Jan 2539.48
Dec 2439.42
Dec 2439.17
Dec 2441.06
Dec 2441.4
Nov 2440.07
Nov 2439.64
Nov 2439.99
Nov 2441.17
Nov 2439.65
Oct 2444.11
Oct 2444.73
Free Cash Flow Yield
1%1.5%2%2.5%3%3.5%med 2.22%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IDXX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 263.09%
Sep 262.92%
Aug 262.81%
Aug 262.8%
Aug 262.83%
Aug 262.66%
Jul 262.41%
Jul 262.48%
Jul 262.38%
Jul 262.39%
Jul 262.42%
Jun 262.44%
Jun 262.4%
Jun 262.4%
Jun 262.4%
May 262.39%
May 262.41%
May 262.55%
May 262.41%
May 262.32%
Apr 262.32%
Apr 262.23%
Apr 262.34%
Apr 262.31%
Mar 262.36%
Mar 262.28%
Mar 262.29%
Mar 262.16%
Feb 262%
Feb 262.07%
Feb 261.89%
Feb 261.85%
Jan 261.78%
Jan 261.72%
Jan 261.66%
Jan 261.67%
Jan 261.78%
Dec 251.73%
Dec 251.7%
Dec 251.69%
Dec 251.67%
Nov 251.58%
Nov 251.64%
Nov 251.73%
Nov 251.68%
Oct 251.53%
Oct 251.5%
Oct 251.52%
Oct 251.56%
Oct 251.53%
Sep 251.52%
Sep 251.47%
Sep 251.5%
Sep 251.5%
Aug 251.49%
Aug 251.49%
Aug 251.48%
Aug 251.46%
Aug 251.92%
Jul 251.82%
Jul 252%
Jul 251.93%
Jul 251.88%
Jun 251.94%
Jun 251.97%
Jun 251.97%
Jun 251.96%
May 252.01%
May 252.05%
May 251.99%
May 252.1%
May 252.18%
Apr 252.23%
Apr 252.37%
Apr 252.49%
Apr 252.48%
Mar 252.34%
Mar 252.32%
Mar 252.35%
Mar 252.27%
Feb 252.23%
Feb 252.15%
Feb 252.17%
Feb 252.09%
Jan 252.28%
Jan 252.21%
Jan 252.3%
Jan 252.3%
Jan 252.32%
Dec 242.32%
Dec 242.34%
Dec 242.23%
Dec 242.21%
Nov 242.28%
Nov 242.31%
Nov 242.29%
Nov 242.22%
Nov 242.31%
Oct 242.25%
Oct 242.22%
Price to Sales
810121416med 10.38Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IDXX Price to Sales by quarter
PeriodPrice to Sales
Sep 268.88
Sep 269.42
Aug 269.76
Aug 269.8
Aug 269.69
Aug 2610.32
Jul 2610.07
Jul 269.81
Jul 2610.22
Jul 2610.15
Jul 2610.05
Jun 269.94
Jun 2610.13
Jun 2610.1
Jun 2610.13
May 2610.15
May 2610.08
May 269.53
May 2610.09
May 2610.56
Apr 2610.53
Apr 2610.97
Apr 2610.48
Apr 2610.6
Mar 2610.39
Mar 2610.74
Mar 2610.68
Mar 2611.32
Feb 2612.22
Feb 2611.83
Feb 2612.1
Feb 2612.39
Jan 2612.89
Jan 2613.34
Jan 2613.75
Jan 2613.71
Jan 2612.88
Dec 2513.23
Dec 2513.46
Dec 2513.53
Dec 2513.72
Nov 2514.47
Nov 2513.95
Nov 2513.26
Nov 2513.62
Oct 2512.54
Oct 2512.76
Oct 2512.65
Oct 2512.27
Oct 2512.57
Sep 2512.59
Sep 2513.07
Sep 2512.77
Sep 2512.81
Aug 2512.89
Aug 2512.86
Aug 2512.96
Aug 2513.11
Aug 2511.08
Jul 2511.69
Jul 2510.64
Jul 2511.03
Jul 2511.31
Jun 2510.99
Jun 2510.84
Jun 2510.81
Jun 2510.86
May 2510.62
May 2510.37
May 2510.72
May 2510.17
May 259.76
Apr 259.19
Apr 258.64
Apr 258.21
Apr 258.27
Mar 258.73
Mar 258.84
Mar 258.72
Mar 259.03
Feb 259.18
Feb 259.51
Feb 259.52
Feb 259.84
Jan 259.03
Jan 259.32
Jan 258.97
Jan 258.95
Jan 258.9
Dec 248.88
Dec 248.83
Dec 249.25
Dec 249.33
Nov 249.03
Nov 248.93
Nov 249.01
Nov 249.27
Nov 248.93
Oct 249.86
Oct 249.99
EV/EBITDA
2530354045med 30.76Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IDXX EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2625.55
Sep 2627.07
Aug 2628.04
Aug 2628.13
Aug 2627.84
Aug 2629.61
Jul 2629.31
Jul 2628.55
Jul 2629.74
Jul 2629.54
Jul 2629.25
Jun 2628.92
Jun 2629.47
Jun 2629.4
Jun 2629.47
May 2629.54
May 2629.33
May 2627.76
May 2629.36
May 2630.7
Apr 2630.62
Apr 2631.86
Apr 2630.47
Apr 2630.81
Mar 2630.22
Mar 2631.22
Mar 2631.04
Mar 2632.88
Feb 2635.44
Feb 2634.32
Feb 2635.34
Feb 2636.18
Jan 2637.61
Jan 2638.9
Jan 2640.09
Jan 2639.98
Jan 2637.58
Dec 2538.6
Dec 2539.26
Dec 2539.47
Dec 2540.02
Nov 2542.16
Nov 2540.67
Nov 2538.68
Nov 2539.71
Oct 2536.88
Oct 2537.53
Oct 2537.21
Oct 2536.11
Oct 2536.97
Sep 2537.03
Sep 2538.4
Sep 2537.54
Sep 2537.65
Aug 2537.88
Aug 2537.8
Aug 2538.1
Aug 2538.51
Aug 2534.37
Jul 2536.24
Jul 2533.05
Jul 2534.23
Jul 2535.09
Jun 2534.11
Jun 2533.64
Jun 2533.56
Jun 2533.7
May 2532.98
May 2532.23
May 2533.27
May 2531.61
May 2530.37
Apr 2528.61
Apr 2526.94
Apr 2525.63
Apr 2525.81
Mar 2527.23
Mar 2527.55
Mar 2527.19
Mar 2528.14
Feb 2528.59
Feb 2529.59
Feb 2529.68
Feb 2530.68
Jan 2528.21
Jan 2529.08
Jan 2528.02
Jan 2527.94
Jan 2527.78
Dec 2427.74
Dec 2427.57
Dec 2428.87
Dec 2429.1
Nov 2428.19
Nov 2427.89
Nov 2428.13
Nov 2428.94
Nov 2427.89
Oct 2431.13
Oct 2431.55
Price/Operating Cashflow
2030405060med 39.18Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IDXX Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2629.55
Sep 2631.35
Aug 2632.5
Aug 2632.61
Aug 2632.26
Aug 2634.36
Jul 2637.12
Jul 2636.14
Jul 2637.68
Jul 2637.42
Jul 2637.04
Jun 2636.62
Jun 2637.32
Jun 2637.24
Jun 2637.32
May 2637.42
May 2637.14
May 2635.11
May 2637.19
May 2638.58
Apr 2638.48
Apr 2640.06
Apr 2638.28
Apr 2638.72
Mar 2637.96
Mar 2639.25
Mar 2639.01
Mar 2641.37
Feb 2644.65
Feb 2643.22
Feb 2646.33
Feb 2647.45
Jan 2649.35
Jan 2651.08
Jan 2652.66
Jan 2652.51
Jan 2649.32
Dec 2550.68
Dec 2551.55
Dec 2551.84
Dec 2552.57
Nov 2555.42
Nov 2553.44
Nov 2550.79
Nov 2552.15
Oct 2555.88
Oct 2556.89
Oct 2556.41
Oct 2554.7
Oct 2556.03
Sep 2556.13
Sep 2558.25
Sep 2556.92
Sep 2557.08
Aug 2557.45
Aug 2557.31
Aug 2557.78
Aug 2558.42
Aug 2544.97
Jul 2547.46
Jul 2543.21
Jul 2544.79
Jul 2545.93
Jun 2544.62
Jun 2544
Jun 2543.89
Jun 2544.08
May 2543.11
May 2542.12
May 2543.51
May 2541.29
May 2539.63
Apr 2538.54
Apr 2536.25
Apr 2534.44
Apr 2534.69
Mar 2536.64
Mar 2537.09
Mar 2536.59
Mar 2537.89
Feb 2538.51
Feb 2539.89
Feb 2539.91
Feb 2541.27
Jan 2537.89
Jan 2539.08
Jan 2537.64
Jan 2537.53
Jan 2537.3
Dec 2437.25
Dec 2437.01
Dec 2438.79
Dec 2439.11
Nov 2437.86
Nov 2437.46
Nov 2437.79
Nov 2438.9
Nov 2437.46
Oct 2438.49
Oct 2439.03
Price to Book
2025303540med 28.83Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
IDXX Price to Book by quarter
PeriodPrice to Book
Sep 2625.07
Sep 2626.59
Aug 2627.57
Aug 2627.66
Aug 2627.37
Aug 2629.14
Jul 2628.78
Jul 2628.02
Jul 2629.21
Jul 2629.01
Jul 2628.71
Jun 2628.39
Jun 2628.93
Jun 2628.87
Jun 2628.94
May 2629.01
May 2628.79
May 2627.22
May 2628.83
May 2628.31
Apr 2628.24
Apr 2629.4
Apr 2628.09
Apr 2628.42
Mar 2627.86
Mar 2628.8
Mar 2628.63
Mar 2630.35
Feb 2632.77
Feb 2631.71
Feb 2632.29
Feb 2633.07
Jan 2634.4
Jan 2635.6
Jan 2636.7
Jan 2636.6
Jan 2634.37
Dec 2535.32
Dec 2535.93
Dec 2536.13
Dec 2536.64
Nov 2538.63
Nov 2537.24
Nov 2535.4
Nov 2536.35
Oct 2534.7
Oct 2535.32
Oct 2535.02
Oct 2533.96
Oct 2534.79
Sep 2534.85
Sep 2536.17
Sep 2535.34
Sep 2535.44
Aug 2535.67
Aug 2535.58
Aug 2535.88
Aug 2536.27
Aug 2530.08
Jul 2531.74
Jul 2528.9
Jul 2529.95
Jul 2530.72
Jun 2529.84
Jun 2529.42
Jun 2529.35
Jun 2529.48
May 2528.83
May 2528.17
May 2529.1
May 2527.61
May 2526.5
Apr 2522.44
Apr 2521.11
Apr 2520.06
Apr 2520.2
Mar 2521.34
Mar 2521.6
Mar 2521.31
Mar 2522.07
Feb 2522.43
Feb 2523.23
Feb 2522.61
Feb 2523.39
Jan 2521.47
Jan 2522.14
Jan 2521.33
Jan 2521.26
Jan 2521.14
Dec 2421.11
Dec 2420.97
Dec 2421.98
Dec 2422.16
Nov 2421.45
Nov 2421.22
Nov 2421.41
Nov 2422.04
Nov 2421.23
Oct 2423.6
Oct 2423.93
IDEXX Laboratories, Inc.
IDXX
Stockpicker

Video analysis: IDXX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IDXX

Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)

defenseworld.net · 11 Sep 2026

Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)

InMode (NASDAQ: INMD - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings. Risk and Volatility InMode has a beta of 1.86,

Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock

fool.com · 10 Sep 2026

Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock

The transaction involved 2,203 shares at $532.08 per share for a total value of ~$1.2 million. The director traded shares equal to 23% of the stake held before the filing.

Baird Financial Group Inc. Sells 6,500 Shares of IDEXX Laboratories, Inc. $IDXX

defenseworld.net · 10 Sep 2026

Baird Financial Group Inc. Sells 6,500 Shares of IDEXX Laboratories, Inc. $IDXX

Baird Financial Group Inc. decreased its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 7.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 76,035 shares of the company's stock after selling 6,500 shares during the period. Baird Financial Group Inc. owned 0.10% of

Arizona State Retirement System Purchases 1,074 Shares of IDEXX Laboratories, Inc. $IDXX

defenseworld.net · 10 Sep 2026

Arizona State Retirement System Purchases 1,074 Shares of IDEXX Laboratories, Inc. $IDXX

Arizona State Retirement System raised its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,772 shares of the company's stock after acquiring an additional 1,074 shares during the quarter.

IDEXX Laboratories, Inc. $IDXX Stake Boosted by California State Teachers Retirement System

defenseworld.net · 8 Sep 2026

IDEXX Laboratories, Inc. $IDXX Stake Boosted by California State Teachers Retirement System

California State Teachers Retirement System raised its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 50,115.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 61,590,848 shares of the company's stock after purchasing an additional 61,468,194 shares

Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?

zacks.com · 3 Sep 2026

Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

Baron Focused Growth Fund Q2 2026 Portfolio Update

seekingalpha.com · 3 Sep 2026

Baron Focused Growth Fund Q2 2026 Portfolio Update

Baron Focused Growth Fund rebounded in Q2 from a disappointing start to the year, with the Fund gaining 13.26% compared with a gain of 24.02% for the Russell 2500 Growth Index. We remain steadfast in our commitment to long-term investing in competitively advantaged, growth businesses. As of June 30, 2026, the Fund owned 28 investments.

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

businesswire.com · 31 Aug 2026

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, from 10:45 am – 11:20 am (ET). A live audio webcast of the fireside chat will be available through.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.